Systemic Burden of Gout Save

Supported by:

Speaker bios:

Robert Terkeltaub, M.D.
Robert Terkeltaub, M.D. is Professor Emeritus of Medicine, Division of Rheumatology, Autoimmunity and Inflammation, University of California, San Diego. After earning his medical degree from McGill University in Montreal, Canada, Dr. Terkeltaub completed postdoctoral training in Immunopathology research at Scripps Research Institute, La Jolla, CA. His research concentrates on gout and ectopic calcification phenotypes of crystal deposition disease, gout clinical trials and treatment guidelines and outcomes in the disease, and the interfaces of inflammation, urate metabolism, and skeletal biology in these disorders. Dr. Terkeltaub has ~340 publications with over ~34,000 citations, has edited 2 textbooks, and has served as co-Editor and first ever Review Articles Editor of Arthritis and Rheumatology. Among his named lectureships was the 6th Morris Ziff Distinguished Lecturer at UT Southwestern Medical Center, and the 1st Malawista Memorial Lecturer at ACR. He also is Honorary Professor at Qingdao University, China. Dr. Terkeltaub has a long record of service on multiple editorial boards and scientific advisory committees, and is founding President of G-CAN (Gout, Hyperuricemia, and Drystal-Associated Disease Research Network).

Nicola Dalbeth, MBChB MD FRACP FRSNZ
Professor Nicola Dalbeth is a rheumatologist based in Auckland, New Zealand. She leads a research programme focusing on the mechanisms, impact, and treatment of gout. She has been principal investigator of trials for novel therapeutic agents and treatment strategies for gout and has led international initiatives to define central concepts of the disease, including nomenclature, staging, and response to treatment. She was a member of the core oversight team for the 2020 American College of Rheumatology (ACR) Gout Management Guidelines, and a steering committee member on the 2015 ACR/ European Alliance of Associations for Rheumatology gout classification project.

Ted R. Mikuls, MD, MSPH
Dr. Mikuls is a rheumatologist and epidemiologist whose research focuses on the epidemiology, pathogenesis, and outcomes of rheumatoid arthritis and gout. He is actively engaged in clinical/translational research activities and has received research funding from the National Institutes of Health, U.S. Department of Defense, Veterans Affairs, the Rheumatology Research Foundation, and industry. He has extensive experience conducting multicenter, multidisciplinary research studies, serving as the principal investigator for the multicenter Veterans Affairs Rheumatoid Arthritis registry since its inception in 2003. He has served on multiple national study sections, including those convened by the National Institutes of Health, Veterans Affairs, and the Rheumatology Research Foundation. He previously chaired the American College of Rheumatology Subcommittee for Practice Guidelines, served on the Food and Drug Administration’s Arthritis Advisory Committee, and was the lead editor for the textbook "A Color Handbook – Rheumatology."